Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure
Authors:
- Stuart D KatzSKStuart D Katz
- Kujtim BalidemajKBKujtim Balidemaj
- Shunichi HommaSHShunichi Homma
- Henry WuHWHenry Wu
- Jie WangJWJie Wang
- Simon MaybaumSMSimon Maybaum
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- EFFECTS OF SILDENAFIL ON THE RELAXATION OF HUMAN CORPUS CAVERNOSUM TISSUE IN VITRO AND ON THE ACTIVITIES OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ISOZYMESJournal of Urology, 1998
- Vasodilatory effects of B-type natriuretic peptide are impaired in patients with chronic heart failureAmerican Heart Journal, 1998
- Endothelium-dependent vasodilatation is not selectively impaired in patients with chronic heart failure secondary to valvular heart disease and congenital heart diseaseEuropean Heart Journal, 1996
- Exercise-induced vasodilation in forearm circulation of normal subjects and patients with congestive heart failure: Role of endothelium-derived nitric oxideJACC, 1996
- Cyclic nucleotide phosphodiesterases: functional implications of multiple isoformsPhysiological Reviews, 1995
- Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failureJACC, 1992
- Endothelium-dependent vasodilation is attenuated in patients with heart failure.Circulation, 1991
- Regulatory Functions of the Vascular EndotheliumNew England Journal of Medicine, 1990
- Cyclic GMP and mechanisms of vasodilationPharmacology & Therapeutics, 1989
- A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failureJournal of Clinical Investigation, 1968